Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Executive Function Training Program for Children With ASD

31 de agosto de 2026 atualizado por: Seoul National University Bundang Hospital

A Randomized Controlled Trial for the Development and Validation of an Executive Function Training Program for Elementary School Students

The goal of this clinical trial is to learn whether a structured executive function training program can improve executive function, adaptive behavior, and self-regulation in elementary school students with autism spectrum disorder (ASD). The main questions it aims to answer are:

Does the program improve participants' executive function skills and their ability to use these skills in daily life? Does the program improve participants' adaptive behavior and self-regulation?

Researchers will compare participants who receive the executive function training program with participants in a waitlist control group to determine whether the program is effective.

Participants will be randomly assigned to either the intervention group or the waitlist control group and will complete assessments before and after the intervention. The intervention consists of a structured, group-based program provided once a week for 12 weeks. Children participate in sessions designed to teach and practice executive function strategies, while their parents participate in parent education and review of home practice to support the use of these skills in daily life.

The program focuses on skills such as planning and prioritizing, organization, time management and task initiation, emotional and impulse control, and flexible thinking. Participants practice applying these strategies to situations encountered at home, at school, and in everyday life.

Visão geral do estudo

Status

Ativo, não recrutando

Descrição detalhada

Executive function refers to a set of skills that support goal-directed behavior and independent functioning, including planning, organization, task initiation, time management, emotional and impulse control, flexible thinking, working memory, and self-monitoring. Difficulties in executive function may affect how children with autism spectrum disorder (ASD) manage everyday demands at home, at school, and in social situations. These difficulties may also be related to adaptive functioning and self-regulation.

This study evaluates a structured executive function training program developed for elementary school students with ASD. The program is designed to help children understand executive function strategies, practice them in structured activities, and apply them to situations encountered in everyday life. Rather than focusing only on performance on cognitive tasks, the intervention emphasizes the practical use of executive function skills for daily activities, school routines, emotional and behavioral regulation, and interactions with others.

The program is delivered in a group format over 12 weekly sessions. Intervention sessions use explicit instruction, therapist modeling, guided practice, role-play and other activities, feedback, and home practice. The major areas addressed include planning and prioritizing, organization, time management and task initiation, emotional and impulse control, and flexible thinking. Visual materials and age-appropriate activities are used to help children understand and practice the strategies.

Parents participate in a parallel parent component. They review the skills taught to their children, receive guidance on supporting the use of these strategies, and review the child's home practice with the intervention team. Parent involvement is intended to promote generalization of skills learned during the sessions to everyday settings.

Participants are randomly assigned to an intervention group or a waitlist control group. After the initial intervention period and post-intervention assessment, participants in the waitlist control group are also offered the program. The study examines whether participation in the program is associated with improvement in executive function and its use in daily life, as well as adaptive behavior, self-regulation, and related psychosocial functioning.

Tipo de estudo

Intervencional

Inscrição (Real)

40

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Gyeonggi-do
      • Seongnam-si, Gyeonggi-do, Coréia do Sul, 13620
        • Seoul National University Bundang Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Children aged 9 to 12 years who are attending elementary school
  • Diagnosis of autism spectrum disorder (ASD) based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
  • Full-scale intelligence quotient (IQ) of 70 or higher
  • Ability to understand the study procedures and participate in the intervention program
  • Availability of a parent or legal guardian who is able to participate in the parent sessions and study assessments

Exclusion Criteria:

  • Presence of a severe neurological or medical condition that may interfere with participation in the study
  • Presence of a severe psychiatric or behavioral condition that may interfere with participation in the group-based intervention
  • Significant sensory or physical impairment that would prevent participation in the intervention or assessments
  • Concurrent participation in another structured intervention program targeting executive function during the study period

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Executive Function Training Group
Participants receive a structured, group-based executive function training program once a week for 12 weeks. The program includes an 80-minute child session and a 65-minute parent session each week. Parents receive education on the same executive function topics taught to their children and review home practice to support the application and generalization of these skills in daily life.
A 12-week, structured, group-based executive function training program delivered once weekly to elementary school students aged 9-12 years with autism spectrum disorder (ASD) and their parents. Each weekly session includes an 80-minute child session and a 65-minute parent session. The child sessions use explicit instruction, modeling, guided practice, role-play, feedback, and home practice to teach and practice executive function strategies related to planning and prioritizing, organization, time management and task initiation, emotional and impulse control, and flexible thinking. In parallel, parents receive education on the same executive function topics taught to their children and review their child's home practice. Parent involvement is designed to help children apply and generalize the executive function strategies learned in the program to daily life at home, at school, and in other everyday situations.
Sem intervenção: Waitlist Control Group
Participants do not receive the executive function training program during the initial 12-week intervention period. After completion of the post-intervention assessment, participants in the waitlist control group are offered the same executive function training program.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Executive Function as Assessed by the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The BRIEF-2 is a parent-report questionnaire that assesses executive function behaviors in children's everyday life. The Global Executive Composite (GEC), index scores, and individual clinical scale scores will be analyzed to evaluate changes in different aspects of executive functioning. Higher T-scores indicate greater difficulties with executive functioning, whereas lower T-scores indicate fewer difficulties.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Adaptive Behavior as Assessed by the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The Vineland-3 is a standardized measure of adaptive functioning in everyday life. The Adaptive Behavior Composite (ABC) score will be used as the primary outcome measure. Domain scores for Communication, Daily Living Skills, and Socialization will also be analyzed. Higher scores indicate better adaptive functioning.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Emotion Regulation as Assessed by the Emotion Regulation Checklist (ERC)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The Emotion Regulation Checklist (ERC) is a 24-item questionnaire that assesses children's emotional regulation and emotional lability/negativity. Items are rated on a 4-point scale from 1 (Never) to 4 (Always). Scores for the Emotion Regulation and Lability/Negativity subscales will be analyzed, with higher Emotion Regulation scores indicating better emotion regulation and higher Lability/Negativity scores indicating greater emotional dysregulation.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Academic Self-Regulation as Assessed by the Academic Self-Regulation Questionnaire (SRQ-A)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The Academic Self-Regulation Questionnaire (SRQ-A) is a child-report measure that assesses children's reasons for engaging in school-related behaviors. It includes four regulatory styles: external regulation, introjected regulation, identified regulation, and intrinsic motivation. Items are rated on a 4-point scale, with higher subscale scores indicating greater endorsement of the corresponding regulatory style. Subscale scores and the Relative Autonomy Index (RAI) will be analyzed, with higher RAI scores indicating more autonomous or self-determined regulation.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Prosocial Self-Regulation as Assessed by the Prosocial Self-Regulation Questionnaire (SRQ-P)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The Prosocial Self-Regulation Questionnaire (SRQ-P) is a child-report measure that assesses children's reasons for engaging in prosocial behaviors. It includes three regulatory styles: external regulation, introjected regulation, and identified regulation. Items are rated on a 4-point scale, with higher subscale scores indicating greater endorsement of the corresponding regulatory style. Subscale scores will be analyzed to assess changes in the regulation of prosocial behavior.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Inhibitory Control as Assessed by the Stroop Test
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The Stroop Test is a performance-based measure used to assess inhibitory control and cognitive interference. Performance indices derived from the Stroop task will be analyzed, with better performance reflecting greater inhibitory control and ability to manage cognitive interference.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Cognitive Flexibility as Assessed by the Children's Color Trails Test (CCTT)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The CCTT is a performance-based measure of attention, sequencing, and cognitive flexibility in children. Performance indices from the CCTT will be analyzed to assess changes in attentional control and cognitive flexibility, including the ability to shift between task demands.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Cognitive Flexibility as Assessed by the Wisconsin Card Sorting Test (WCST)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The WCST is a performance-based measure of executive functioning that assesses cognitive flexibility, concept formation, and the ability to shift cognitive sets in response to changing feedback. Performance indices from the WCST will be analyzed to assess changes in cognitive flexibility.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Autism-Related Social Functioning as Assessed by the Social Responsiveness Scale, Second Edition (SRS-2)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The SRS-2 is a questionnaire that assesses social functioning and autism-related social difficulties. Total and subscale scores will be analyzed. Higher scores indicate greater difficulties in social functioning and greater severity of autism-related social characteristics.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Emotional and Behavioral Problems as Assessed by the Child Behavior Checklist (CBCL)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Description: range of emotional and behavioral problems in children. Composite and syndrome scale scores will be analyzed. Higher scores indicate greater emotional and behavioral difficulties.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Depressive Symptoms as Assessed by the Children's Depression Inventory (CDI)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The CDI is a child-report questionnaire used to assess depressive symptoms in children. The total score will be analyzed, with higher scores indicating greater depressive symptoms.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Anxiety Symptoms as Assessed by the State-Trait Anxiety Inventory for Children (STAIC)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The STAIC is a child-report questionnaire that assesses state anxiety and trait anxiety in children. State Anxiety and Trait Anxiety scores will be analyzed separately, with higher scores indicating greater anxiety.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
Parenting Stress as Assessed by the Korean Parenting Stress Index, Fourth Edition, Short Form (K-PSI-4-SF)
Prazo: Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention
The K-PSI-4-SF is a parent-report questionnaire that assesses parenting stress. The Total Stress score and subscale scores will be analyzed, with higher scores indicating greater levels of parenting stress.
Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Hee Jeong Yoo, MD., Ph.D., Seoul National University College of Medicine, Child and Adolescent Psychiatry Clinic Seoul National University Bundang Hospital

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

12 de março de 2026

Conclusão Primária (Estimado)

1 de janeiro de 2027

Conclusão do estudo (Estimado)

1 de janeiro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

31 de agosto de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

31 de agosto de 2026

Primeira postagem (Real)

3 de setembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

3 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

31 de agosto de 2026

Última verificação

1 de abril de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever